Literature DB >> 12183287

Amino acid substitutions at position 69 of the reverse transcriptase of human immunodeficiency virus type 1 are frequent in zalcitabine-naive antiretroviral-drug-experienced patients.

Brigitte Montes, Michel Segondy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183287      PMCID: PMC127403          DOI: 10.1128/AAC.46.9.3110-3111.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV-1 in relation to treatment with nucleoside analogue RT inhibitors.

Authors:  Brigitte Montes; Michel Segondy
Journal:  J Med Virol       Date:  2002-03       Impact factor: 2.327

2.  Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.

Authors:  M A Winters; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.

Authors:  M N Rousseau; L Vergne; B Montes; M Peeters; J Reynes; E Delaporte; M Segondy
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

4.  Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Authors:  A K Iversen; R W Shafer; K Wehrly; M A Winters; J I Mullins; B Chesebro; T C Merigan
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine.

Authors:  J E Fitzgibbon; R M Howell; C A Haberzettl; S J Sperber; D J Gocke; D T Dubin
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.